-
Intuitive Surgical Inc. (ISRG) prevailed in a civil lawsuit that accused it of negligence in its training of doctors using the company's surgical robot machines, a victory as it looks to counter...
-
Iceland's new prime minister, Sigmundur David Gunnlaugsson, said late Thursday that he aims to remove capital controls that have been in place since the nation's economic collapse several years...
-
Elan Corp. (ELN, DRX.DB) Thursday rejected the most recent approach by New York-based pharmaceutical investor Royalty Pharma AG, which values the company at around $6.4 billion.
-
NEW BRUNSWICK, N.J.--Johnson & Johnson (JNJ) said its pharmaceutical unit plans to submit more than 10 new-product applications by 2017, as the health-care heavyweight hopes to build on the...
-
Dissident Vivus Inc. (VVUS) shareholder First Manhattan Co. nominated three more director candidates following the drug maker's expansion of its board size.
-
Average premiums in California's new online health-insurance marketplace for consumers will not be as high as predicted by actuaries, though they will vary widely, according to the agency setting...
-
Elan rejected Royalty Pharma's increased $6.
-
Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) Thursday said treatment with its drug liraglutide led to an average 8% weight loss in patients in a 56-week phase 3a clinical study.
-
Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small generic and...
-
NEW BRUNSWICK, N.J.--Johnson & Johnson (JNJ) said its pharmaceutical unit plans to submit more than 10 new product applications by 2017, as the health-care heavyweight hopes to build on the...
-
The U.S. Food and Drug Administration slapped an import ban on Indian drugmaker Wockhardt Ltd. (532300.BY) after one of the company's plants failed an FDA safety inspection.
-
NEW BRUNSWICK, N.J.--Johnson & Johnson (JNJ) said its pharmaceutical unit plans to submit more than 10 new product applications by 2017, as the health-care giant hopes to build on the...
-
Johnson & Johnson (JNJ) unit Janssen Pharmaceutical Co. said it plans to submit more than 10 new product filings and more than 25 significant brand line extensions by 2017, which would amount...
-
Royalty Pharma AG, the New York-based pharmaceutical investor bidding around $6.4 billion in cash for drugmaker Elan Corp. (ELN) Thursday said it was lowering the threshold for shareholder...
-
Dissident Vivus Inc. (VVUS) shareholder First Manhattan Co. nominated three more director candidates following the drug maker's expansion of its board size.
-
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a...
-
Apricus Biosciences Inc. (APRI) unveiled plans to offer shares of common stock and warrants, while an affiliate of Lehman Brothers Holdings Inc. has commenced an offering of shares of AvalonBay...
-
Fisher & Paykel Healthcare (FPH.NZ) reported Thursday a 20% increase as revenue in its respiratory and acute care product group rises 18%.
-
Pfizer Inc. (PFE) said it plans to shed its majority stake in animal-health company Zoetis Inc. (ZTS), continuing Pfizer's efforts to its hone its focus on drugs and vaccines for humans.
-
Concerned about the need to fight antibiotic resistance and possible bioterrorist attacks, the U.S. government will give drug maker GlaxoSmithKline PLC (GSK, GSK.LN) up to $200 million over the...
-
Shares of Bristol-Myers Squibb Co. (BMY) jumped more than 6% Wednesday after Citigroup (C) raised its rating on the company's shares to buy from neutral, as an analyst at the brokerage says the...
-
U.S. stocks showed solid gains in early-afternoon action Wednesday, recovering a little from a dip on Federal Reserve Chairman Ben Bernanke saying tapering of the central bank's bond buying could...
-
European stock markets climbed to an almost five-year high on Wednesday, after U.S. Federal Reserve Chairman Ben Bernanke calmed fears that the central bank will soon fade out its easing program.
-
Pfizer Inc. (PFE) plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. (ZTS) through a voluntary exchange offer with its shareholders.
-
Among the companies with shares expected to actively trade in Wednesday's session are Saks Inc. (SKS), Zale Corp. (ZLC) and Multiband Corp. (MBND).
-
Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis stock at a 7 percent discount.
-
Pfizer Inc. (PFE) plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. (ZTS) through a voluntary exchange offer with its shareholders.
-
European stock markets slid from multiyear highs on Wednesday, as investors stayed cautious ahead of comments from U.S. Federal Reserve Chairman Ben Bernanke.
-
The pharmaceutical maker plans to sell its majority stake in animal-health company Zoetis, continuing its push to focus on drugs and vaccines not made for four-legged friends.
-
Drug group GlaxoSmithKline PLC (GSK.LN) said Wednesday that it has been awarded up to $200 million by the U.S. government to develop new antibiotics.
-
European stock markets slipped from multiyear highs in downbeat action on Wednesday, as investors stayed cautious ahead of comments from the U.S. Federal Reserve Chairman Ben Bernanke.
-
Bristol Myers Squibb was upgraded to buy from neutral as well as its price target to $55 from $33.
-
Roche Holding AG (ROG.VX) Wednesday told the IFCC Euromedlab in Milan, Italy that it will soon introduce the cobas 8100 automated workflow series, a new solution for use in diagnostic laboratories.
-
GlaxoSmithKline PLC (GSK) said it would close an Australian tablet-packaging facility and lay off 120 workers, joining a string of manufacturers that have shut factories, slashed jobs and...
-
GlaxoSmithKline PLC (GSK) said it would close an Australian tablet-packaging facility and lay off 120 workers, joining a string of manufacturers that have shut factories, slashed jobs and...
-
The drug giant is looking to prop up shareholder value in face of stiff competition from makers of less-costly generics.
-
GlaxoSmithKline PLC (GSK) said Wednesday it was closing an Australian tablet-packaging plant, leading to 120 job losses.
-
Merck (MRK) said it has entered into an accelerated share repurchase agreement with Goldman Sachs Group Inc. (GS) to repurchase $5 billion of the drug manufacturer's common stock, as the company...
-
Gilead Sciences Inc. (GILD) said the marketing authorization application for its new hepatitis C drug has been validated by the European Medicines Agency and granted accelerated assessment.
-
Gilead Sciences Inc. (GILD) said the marketing authorization application for its new hepatitis C drug has been validated by the European Medicines Agency and granted accelerated assessment.
-
U.S. stocks rose on Tuesday, with the Dow industrials and S&P 500 finishing at record highs, after comments from two Federal Reserve officials suggested that the central bank is not close to...
-
An experimental drug being developed by Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SNY) showed promising results during a small, mid-stage clinical trial in treating a subset of patients...
-
Medtronic Inc.'s (MDT) fiscal fourth-quarter sales grew roughly 4%, but expenses related to employee layoffs and manufacturing consolidation caused earnings to fall 2.2%, masking the...
-
Former SAC Capital Advisors portfolio manager Mathew Martoma said the government is impeding his ability to defend against criminal insider trading charges by trying to link him to an alleged...
-
The Oklahoma City medical examiner has reduced the official, confirmed death toll to 24 in the wake of a While fears remain that the count could again rise -- the medical examiner's language...
-
As the federal government squeezes payments for private Medicare plans, Humana Inc. (HUM), the big health insurer most tethered to the government health program, has no plans to shift gears.
-
The medical-device maker’s adjusted profits and revenue exceeded Wall Street’s expectations.
-
Medtronic Inc.'s (MDT) fiscal fourth-quarter earnings fell 2.2% as restructuring charges masked the medical-devices company's improved revenue and margins.
Account
